tDCS and Cognitive Training for Alzheimer Disease
Phase-Based Progress Estimates
Effectiveness
Safety
Alzheimer Disease
tDCS and Cognitive Training - OtherEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial will test whether administering transcranial direct current stimulation (tDCS) at 4.0 mA, rather than the conventional 2mA, will produce more significant improvements in people with Alzheimer's Disease.
Treatment Effectiveness
Effectiveness Progress
Other trials for Alzheimer Disease
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 3 months
3 months
N-Back
Trial Safety
Safety Progress
Other trials for Alzheimer Disease
Trial Design
3 Treatment Groups
2mA Stimulation
1 of 3
4mA Stimulation
1 of 3
SHAM
1 of 3
Active Control
Experimental Treatment
Non-Treatment Group
42 Total Participants · 3 Treatment Groups
Primary Treatment: tDCS and Cognitive Training · Has Placebo Group · N/A
4mA Stimulation
Other
Experimental Group · 1 Intervention: tDCS and Cognitive Training · Intervention Types: Other2mA Stimulation
Other
ActiveComparator Group · 1 Intervention: tDCS and Cognitive Training · Intervention Types: OtherSHAM
Other
ShamComparator Group · 1 Intervention: tDCS and Cognitive Training · Intervention Types: OtherTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months
Who is running the clinical trial?
BrightFocus FoundationOTHER
3 Previous Clinical Trials
246 Total Patients Enrolled
2 Trials studying Alzheimer Disease
190 Patients Enrolled for Alzheimer Disease
BaycrestLead Sponsor
40 Previous Clinical Trials
5,663 Total Patients Enrolled
4 Trials studying Alzheimer Disease
411 Patients Enrolled for Alzheimer Disease
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments